Unknown

Dataset Information

0

Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging.


ABSTRACT: Magnetic liposomes have been frequently used as nanocarriers for targeted drug delivery and magnetic resonance imaging in recent years. Despite great potentials, their morphological/structural instability in the physiological environment still remains an intractable challenge for clinical applications. In this study, stable hybrid liposomal cerasomes (ie, liposomes partially coated with silica) which can co-encapsulate Fe3O4 nanoparticles and the anticancer drug paclitaxel were developed using thin film hydration method. Compared with the drug loaded liposomes, the paclitaxel-loaded magnetic cerasomes (PLMCs) exhibited much higher storage stability and better sustained release behavior. Cellular uptake study showed that the utilization of an external magnetic field significantly facilitated the internalization of PLMCs into cancer cells, resulting in potentiated drug efficacy of killing tumor cells. The T2 relaxivity (r2) of our PLMCs was much higher than that of free Fe3O4 nanoparticles, suggesting increased sensitivity in T2-weighted imaging. Given its excellent biocompatibility also shown in the study, such dual functional PLMC is potentially a promising nanosystem for effective cancer diagnosis and therapy.

SUBMITTER: Cao Z 

PROVIDER: S-EPMC4227624 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Stable cerasomes for simultaneous drug delivery and magnetic resonance imaging.

Cao Zhong Z   Zhu Wenjian W   Wang Wei W   Zhang Chunyang C   Xu Ming M   Liu Jie J   Feng Shi-Ting ST   Jiang Qing Q   Xie Xiaoyan X  

International journal of nanomedicine 20141105


Magnetic liposomes have been frequently used as nanocarriers for targeted drug delivery and magnetic resonance imaging in recent years. Despite great potentials, their morphological/structural instability in the physiological environment still remains an intractable challenge for clinical applications. In this study, stable hybrid liposomal cerasomes (ie, liposomes partially coated with silica) which can co-encapsulate Fe3O4 nanoparticles and the anticancer drug paclitaxel were developed using t  ...[more]

Similar Datasets

| S-EPMC3001231 | biostudies-literature
| S-EPMC5496002 | biostudies-literature
| S-EPMC4199085 | biostudies-literature
| S-EPMC5580964 | biostudies-other
| S-EPMC5836966 | biostudies-literature
| S-EPMC6020541 | biostudies-literature
| S-EPMC2268792 | biostudies-literature
| S-EPMC6181115 | biostudies-literature
| S-EPMC7550427 | biostudies-literature
| S-EPMC4943858 | biostudies-literature